Abstract: A system and process to estimate persuasiveness of public messaging using surveys are disclosed. According to one embodiment, a method comprises selecting survey participants. Pre-screening question responses are received from the survey participants. The survey participants are divided randomly into a control group and a treatment group. The treatment group is shown a creative and a control group is shown nothing or a placebo. After the creative has been shown, participants are asked post-message questions such as purchase intent, favorability of the brand, and brand awareness. Weighting and bias correction are applied to question responses. An effects report is generated that includes an average treatment effect and a backlash probability for the creative, and treatment effects specific to subgroups.

Abstract: A system and method for survey weighting is disclosed. According to one embodiment, a method comprises selecting key survey variables (KSVs) related to the survey; selecting microdata sources that represent a target population; training models using the KSVs as key survey variables; and collecting out-of-sample predictions. The method further comprises making predictions using the models; averaging the predictions over the target population; and generating survey weights using a calibration estimator.

Abstract: Fatty acid-based, pre-cure-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.

Abstract: Fatty acid-based, pre-cure-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.

Abstract: Fatty acid-based, pre-cure-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.

Abstract: Fatty acid-based, pre-cure-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.

Abstract: Fatty acid-based, pre-cure-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.